FOR IMMEDIATE RELEASE: 1 February 2023 CONTACTS: Hugill & Ip Solicitors Marco Raccuia, Head of Finance & Operations E-mail: marco.raccuia@hugillandip.com World Cancer Day – held every 4 February – is the global uniting initiative led by the Union for International Cancer Control (UICC). By raising worldwide awareness, improving education, and catalysing personal, collective and government action, UICC partners…...
Be a Spark of Hope for Cancer Patients – Renew Your Support Today!
As the year comes to a close, I wanted to reach out and ask for your support in our year-end fundraising campaign. Your generosity has the power to ignite a spark of hope for cancer patients and their families who are fighting an incredibly difficult battle. Your contribution will make a real difference…...
AFCR Annual Reception: A Community Effort to Find Cures for Cancer
On December 15, 2022, the Asian Fund for Cancer Research (AFCR) held its annual reception for community support of cancer research in Hong Kong. The event was a great success, thanks to the support of generous donors, attendees, and inspiring speakers who shared their thoughts on the importance of cancer…...
Impact Investment: Interview with Arbele
The Asian Fund for Cancer Research aims to accelerate cancer research and technologies through international collaborations. As part of our mission, AFCR has created the BRACE Award Venture Competition to provide vital support to early-stage biotechs, enabling them to accelerate their innovative therapeutics, diagnostics and cancer prevention products into…...
Promising Cancer Research Programs Need Your Help!
I am writing today to ask for your 2022 Annual Fund renewal gift to the Asian Fund for Cancer Research, and your decision is absolutely crucial! Currently, talented scientists are waiting for funding to pursue potentially life-saving research projects. Generous friends like you will help determine which investigations will be…...
AFCR-Funded Innovative Immunotherapy Received Clinical Trial Approval!
Since 2020 AFCR has funded a novel multi-targeting immunotherapeutic platform that we envisioned could provide a safe and effective treatment for gastrointestinal (GI) cancers. Today I am excited to share with you the program’s recent great progress! With your previous support and funding, the drug indicated for the potential treatment…...
AFCR Congratulates Professor Nancy Ip for Being Appointed as the President of The Hong Kong University of Science and Technology (HKUST)
The Asian Fund for Cancer Research Limited congratulates world-renowned neuroscientist, Nancy Ip, Ph.D., the Morningside Professor of Life Science and Director of the State Key Laboratory of Molecular Neuroscience at The Hong Kong University of Science and Technology (HKUST) on her appointment as its President-Elect beginning October 2022. Prof. Ip…...
Announcement: Chimera Bioengineering is the 2021 BRACE Award Venture Competition Winner
CONTACTS:Asian Fund for Cancer ResearchBradley Gillenwater, Senior Director for Corporate EngagementE-mail: bgillenwater@afcr.org Chimera BioengineeringVlad Hogenhuis, M.D., CEOE-mail: info@chimera.bio Little Dog CommunicationsJessica Yingling, Ph.D., PresidentE-mail: jessica@litldog.com / Phone: 1-858-344-8091 Asian Fund for Cancer Research Announces Chimera Bioengineering as the2021 BRACE Award Venture Competition Winner HONG KONG – Chimera Bioengineering has been…...
